LINZESS Pediatric Approval Gives IRWD a Fresh Catalyst
Ironwood Pharmaceuticals woke up Wednesday with its most significant piece of positive news in months — an FDA approval expanding LINZESS (linaclotide) to pediatric patients aged two and older for functional…
